Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors

Elizabeth S. Fenjves, M. Sofia Ochoa, Over Cabrera, Armando J Mendez, Norma S Kenyon, Luca A Inverardi, Camillo Ricordi

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Background. Erythropoietin (EPO) promotes survival in a variety of cells by mediating antiapoptotic signals through the EPO receptor (R). The authors examined pancreatic islets for the presence of EPO-R to determine whether these cells are protected by EPO from cytokine-induced apoptosis. Methods. Reverse-transcriptase polymerase chain reaction, immunohistology, and Western blots were used to establish the presence and localization of EPO-R on rat, nonhuman primate, and human islets. Islets were exposed to cytokines in the presence and absence of recombinant EPO and apoptosis was measured using a terminal deoxynucleotide transferase-mediated dUTP nick-end labeling assay followed by fluorescence-activated cell sorter analysis. Glucose stimulation indices were measured to assess the effect of EPO on islet function. Results. The presence of EPO-R was demonstrated on islets regardless of species. Recombinant EPO protected islets in culture from cytokine-induced apoptosis in a dose-dependent manner. Furthermore, the presence of EPO in the media does not adversely affect islet function. Conclusions. This is the first demonstration that pancreatic islets express EPO-R and that EPO may prevent islet-cell apoptosis in culture. In vivo trials to evaluate the potential of long-term expression of EPO to augment islet survival in transplantation are underway.

Original languageEnglish
Pages (from-to)1356-1360
Number of pages5
JournalTransplantation
Volume75
Issue number8
DOIs
StatePublished - Apr 27 2003

Fingerprint

Erythropoietin Receptors
Erythropoietin
Islets of Langerhans
Primates
Apoptosis
Cytokines
Survival
Transferases
Reverse Transcriptase Polymerase Chain Reaction

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors. / Fenjves, Elizabeth S.; Ochoa, M. Sofia; Cabrera, Over; Mendez, Armando J; Kenyon, Norma S; Inverardi, Luca A; Ricordi, Camillo.

In: Transplantation, Vol. 75, No. 8, 27.04.2003, p. 1356-1360.

Research output: Contribution to journalArticle

Fenjves, Elizabeth S. ; Ochoa, M. Sofia ; Cabrera, Over ; Mendez, Armando J ; Kenyon, Norma S ; Inverardi, Luca A ; Ricordi, Camillo. / Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors. In: Transplantation. 2003 ; Vol. 75, No. 8. pp. 1356-1360.
@article{bc9fe1b0ce0a49449b22daa9dc2affcd,
title = "Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors",
abstract = "Background. Erythropoietin (EPO) promotes survival in a variety of cells by mediating antiapoptotic signals through the EPO receptor (R). The authors examined pancreatic islets for the presence of EPO-R to determine whether these cells are protected by EPO from cytokine-induced apoptosis. Methods. Reverse-transcriptase polymerase chain reaction, immunohistology, and Western blots were used to establish the presence and localization of EPO-R on rat, nonhuman primate, and human islets. Islets were exposed to cytokines in the presence and absence of recombinant EPO and apoptosis was measured using a terminal deoxynucleotide transferase-mediated dUTP nick-end labeling assay followed by fluorescence-activated cell sorter analysis. Glucose stimulation indices were measured to assess the effect of EPO on islet function. Results. The presence of EPO-R was demonstrated on islets regardless of species. Recombinant EPO protected islets in culture from cytokine-induced apoptosis in a dose-dependent manner. Furthermore, the presence of EPO in the media does not adversely affect islet function. Conclusions. This is the first demonstration that pancreatic islets express EPO-R and that EPO may prevent islet-cell apoptosis in culture. In vivo trials to evaluate the potential of long-term expression of EPO to augment islet survival in transplantation are underway.",
author = "Fenjves, {Elizabeth S.} and Ochoa, {M. Sofia} and Over Cabrera and Mendez, {Armando J} and Kenyon, {Norma S} and Inverardi, {Luca A} and Camillo Ricordi",
year = "2003",
month = "4",
day = "27",
doi = "10.1097/01.TP.0000062862.88375.BD",
language = "English",
volume = "75",
pages = "1356--1360",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors

AU - Fenjves, Elizabeth S.

AU - Ochoa, M. Sofia

AU - Cabrera, Over

AU - Mendez, Armando J

AU - Kenyon, Norma S

AU - Inverardi, Luca A

AU - Ricordi, Camillo

PY - 2003/4/27

Y1 - 2003/4/27

N2 - Background. Erythropoietin (EPO) promotes survival in a variety of cells by mediating antiapoptotic signals through the EPO receptor (R). The authors examined pancreatic islets for the presence of EPO-R to determine whether these cells are protected by EPO from cytokine-induced apoptosis. Methods. Reverse-transcriptase polymerase chain reaction, immunohistology, and Western blots were used to establish the presence and localization of EPO-R on rat, nonhuman primate, and human islets. Islets were exposed to cytokines in the presence and absence of recombinant EPO and apoptosis was measured using a terminal deoxynucleotide transferase-mediated dUTP nick-end labeling assay followed by fluorescence-activated cell sorter analysis. Glucose stimulation indices were measured to assess the effect of EPO on islet function. Results. The presence of EPO-R was demonstrated on islets regardless of species. Recombinant EPO protected islets in culture from cytokine-induced apoptosis in a dose-dependent manner. Furthermore, the presence of EPO in the media does not adversely affect islet function. Conclusions. This is the first demonstration that pancreatic islets express EPO-R and that EPO may prevent islet-cell apoptosis in culture. In vivo trials to evaluate the potential of long-term expression of EPO to augment islet survival in transplantation are underway.

AB - Background. Erythropoietin (EPO) promotes survival in a variety of cells by mediating antiapoptotic signals through the EPO receptor (R). The authors examined pancreatic islets for the presence of EPO-R to determine whether these cells are protected by EPO from cytokine-induced apoptosis. Methods. Reverse-transcriptase polymerase chain reaction, immunohistology, and Western blots were used to establish the presence and localization of EPO-R on rat, nonhuman primate, and human islets. Islets were exposed to cytokines in the presence and absence of recombinant EPO and apoptosis was measured using a terminal deoxynucleotide transferase-mediated dUTP nick-end labeling assay followed by fluorescence-activated cell sorter analysis. Glucose stimulation indices were measured to assess the effect of EPO on islet function. Results. The presence of EPO-R was demonstrated on islets regardless of species. Recombinant EPO protected islets in culture from cytokine-induced apoptosis in a dose-dependent manner. Furthermore, the presence of EPO in the media does not adversely affect islet function. Conclusions. This is the first demonstration that pancreatic islets express EPO-R and that EPO may prevent islet-cell apoptosis in culture. In vivo trials to evaluate the potential of long-term expression of EPO to augment islet survival in transplantation are underway.

UR - http://www.scopus.com/inward/record.url?scp=0037469029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037469029&partnerID=8YFLogxK

U2 - 10.1097/01.TP.0000062862.88375.BD

DO - 10.1097/01.TP.0000062862.88375.BD

M3 - Article

C2 - 12717230

AN - SCOPUS:0037469029

VL - 75

SP - 1356

EP - 1360

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 8

ER -